RETEVMO (selpercatinib) Patient Assistance Program
Don’t let the high cost of brand specialty targeted oncology therapy stand between you and the treatment you need. We help eligible patients access Retevmo (selpercatinib) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Retevmo (selpercatinib) is FDA-approved for adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC), for adult and pediatric patients 12 years and older with advanced or metastatic RET-mutant medullary thyroid cancer requiring systemic therapy, for adult and pediatric patients 12 and older with advanced or metastatic RET fusion-positive thyroid cancer who are radioactive iodine-refractory, and for adults with locally advanced or metastatic solid tumors with a RET gene fusion.
- Without assistance, the retail cost commonly runs approximately $25,000–$30,000 per 30-day supply at standard maintenance doses.
- Through AffordMyPrescriptions, qualifying patients can access Retevmo for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Retevmo available in the U.S. as of 2026. Retevmo is dispensed through a limited specialty pharmacy distribution network.
What is Retevmo Prescription Assistance Program?
The Retevmo Prescription Assistance Program is a manufacturer-sponsored initiative that provides Retevmo at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for cancer patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, RET molecular testing documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Retevmo costs roughly $25,000–$30,000 per 30-day supply through the limited specialty pharmacy distribution network. Discount coupons offer little relief at this price level. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$29,500.00 | Save ~$29,430/mo |
| CVS Pharmacy | ~$30,000.00 | Save ~$29,930/mo |
| Walmart | ~$26,500.00 | Save ~$26,430/mo |
| Costco | ~$25,800.00 | Save ~$25,730/mo |
| Specialty Pharmacy | ~$26,000.00 | Save ~$25,930/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Retevmo Prescription Program?
The Patient Assistance Program is free to apply for and provides Retevmo at no medication cost if approved. But the process involves detailed applications, oncology-team coordination, RET molecular testing documentation, limited specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, molecular-testing documentation, refill management, and annual re-enrollment.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Retevmo:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $25,000–$30,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Retevmo assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Retevmo Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Retevmo:
Retevmo (selpercatinib) is an oral, targeted oncology medicine — a selective RET kinase inhibitor — used to treat advanced cancers driven by RET gene fusions or specific RET mutations. It is approved across multiple cancer types when a RET alteration is confirmed by an FDA-approved test: RET fusion-positive NSCLC, RET-mutant medullary thyroid cancer, RET fusion-positive thyroid cancer, and RET fusion-positive solid tumors.
How It Works:
Retevmo is a highly selective inhibitor designed to block the activity of the RET protein, which drives cancer growth when it becomes overactive due to gene fusions or mutations. By specifically interrupting these abnormal signals, the medication slows the division of cancer cells across various tumor types. Because it is highly selective, it targets RET specifically rather than blocking many different kinases at once.
Form and Use:
The medication is taken as oral capsules twice daily, with or without food, and should be swallowed whole. Dosing for adults and children aged 12 and older is based on body weight, typically set at either 120 mg or 160 mg per dose. Your oncology team will monitor your progress and may adjust the dosage if you experience side effects like high blood pressure or changes in liver tests.
Generic Availability:
As of 2026, there is no FDA-approved generic version of Retevmo available in the U.S. due to active patent and exclusivity protections. While other RET-targeted therapies such as pralsetinib exist, they are not direct generic substitutes. Any decision to use an alternative treatment depends on your specific medical history and is a choice that belongs with your oncology team.
Warnings:
Retevmo carries warnings for potential risks including liver injury, high blood pressure, heart rhythm changes (QT prolongation), and impaired wound healing. It can also cause hemorrhage or hypersensitivity reactions and should not be used during pregnancy due to embryo-fetal toxicity. To ensure safety, your medical team will regularly monitor your liver function and blood pressure throughout your treatment.
FAQ (Frequently Asked Questions)
How Much Does Retevmo Cost Without Insurance?
The retail price commonly runs $25,000–$30,000 per 30-day supply at standard maintenance doses through the limited specialty pharmacy network. Coupon discounts at major pharmacies are modest because the underlying price is so high. Through AffordMyPrescriptions, qualifying patients receive Retevmo at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is The RET Alteration Confirmed?
RET gene fusions and RET mutations are confirmed through molecular testing of the tumor (often a next-generation sequencing panel performed on a biopsy or surgical specimen) or, for medullary thyroid cancer, through germline or tumor genetic testing. Retevmo is approved only for cancers that have been confirmed RET fusion-positive or RET-mutant on FDA-approved testing.
How Is Retevmo Taken?
Retevmo is taken by mouth twice daily, with or without food. Adult dosing is weight-based: 160 mg twice daily for patients ≥50 kg, 120 mg twice daily for patients <50 kg. Capsules should be swallowed whole. Take it at roughly the same times each day.
Are There Other RET Inhibitors I Should Know About?
Yes. Pralsetinib is another approved RET inhibitor used in some RET-altered cancers. Whether it is a clinical fit for you depends on the indication, prior treatments, and tolerability. We mention this directly because if a different therapy on a more accessible assistance pathway would work, that may be a better path than paying for our advocacy on Retevmo.
Can I Get Retevmo Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Retevmo Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent oncology-focused foundations such as the PAN Foundation, HealthWell Foundation, GO2 for Lung Cancer, or the Thyroid Cancer Survivors’ Association, the manufacturer’s copay savings program if you have commercial insurance, or asking your oncology team whether a different RET inhibitor or treatment plan would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Retevmo, our team may be able to help you access assistance programs designed to make brand specialty targeted oncology therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.